Pfizer Inc.
Business and Collaboration Outreach
Save
April 26, 2024 3:46 AM
-
no-reply@q4inc.com
Pfizer Inc. - U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
FDA approval of Pfizer's one-time gene therapy for adults with Hemophilia B.
Pfizer Inc. has added a new press release to its website: U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B Click here for a complete listing of Pfizer Inc. press releases. To u
Similar Emails
Nokia
Nokia enters into an agreement with the French State regarding the sale of leading submarine networks business ASN
Business and Collaboration Outreach
ServiceTitan
See the entire story of how this company joined ServiceTitan
Business and Collaboration Outreach
Nissan Motor Corporation
Nissan CEO Makoto Uchida receives honorary award from the United Kingdom
Business and Collaboration Outreach
Nissan Motor Corporation
Nissan announces senior management appointments
Business and Collaboration Outreach
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Save to Board
This is some text inside of a div block.
This is some text inside of a div block.
1 selected
DoneYou have reached your plans limit
To create or access more boards you need to upgrade.
Saved to “Lululemon” board
1 item added
Dismiss
